These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1198248)

  • 1. [Production, control and consumption of drugs in Mexico (preliminary report)].
    Heredia Duarte A
    Salud Publica Mex; 1975; 17(2):169-80. PubMed ID: 1198248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which factors should influence the choice of drugs?].
    Lakartidningen; 1975 Oct; 72(40):3828-34. PubMed ID: 1177612
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorials: The FDA--reprise.
    Thomison JB
    J Tenn Med Assoc; 1973 Nov; 66(11):1071-2. PubMed ID: 4756263
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug control in the Americas].
    Yakowitz ML
    Bol Oficina Sanit Panam; 1972 Jul; 73(1):28-32. PubMed ID: 4261469
    [No Abstract]   [Full Text] [Related]  

  • 5. What action for rational drug use?
    Khan I
    World Health Forum; 1997; 18(1):83-6. PubMed ID: 9233081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drugs].
    Greppin R
    Z Krankenpfl; 1972 Dec; 65(12):446-51. PubMed ID: 4486551
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of therapeutic equivalence in drug registration and control.
    Idänpään-Heikkilä J
    Ann Clin Res; 1974; 6(0):suppl 11:71-8. PubMed ID: 4850672
    [No Abstract]   [Full Text] [Related]  

  • 8. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 9. [Marketing strategies of the pharmaceutical industry and the consumption of drugs].
    Barros JA
    Rev Saude Publica; 1983 Oct; 17(5):377-86. PubMed ID: 6658355
    [No Abstract]   [Full Text] [Related]  

  • 10. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?
    Silbermann JM
    J Contemp Health Law Policy; 1996; 12(2):607-36. PubMed ID: 8666736
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of latest trends in illegal drug consumption ].
    Tabe M; Ito E; Kouno Y
    Chudoku Kenkyu; 2004 Jul; 17(3):251-8. PubMed ID: 15495684
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of the Food and Drugs sub-committee of the Ceylon Medical Association on the import and manufacture of pharmaceuticals in Ceylon--comments on the Wickremasinghe-Bibile report.
    Ceylon Med J; 1971 Jun; 16(2):122-3. PubMed ID: 5163547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Critical study of anti-microbial agents commercialized in Brazil].
    Baldy JL; Takata PK; Passos JN; Turini TL
    AMB Rev Assoc Med Bras; 1984; 30(11-12):253-60. PubMed ID: 6336009
    [No Abstract]   [Full Text] [Related]  

  • 15. [New classification of narcotic and psychotropic drugs].
    Neurol Neurocir Psiquiatr; 1977; 18(1):53-61. PubMed ID: 876446
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis of drug consumption.
    Fikr V; Federmann J
    Sante Publique (Bucur); 1970; 4():423-37. PubMed ID: 5513287
    [No Abstract]   [Full Text] [Related]  

  • 17. Global opioid consumption: trends, barriers, and diversion.
    Support Care Cancer; 1995 May; 3(3):159. PubMed ID: 7655774
    [No Abstract]   [Full Text] [Related]  

  • 18. Sales statistics in the control of drug abuse in Norway.
    Jøldal B; Halvorsen I
    Bull Narc; 1982; 34(2):57-68. PubMed ID: 6129015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet.
    Lubell J
    Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control of drugs.
    Whittet TD
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:15-9. PubMed ID: 5701292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.